Immix Biopharma (IMMX) EPS (Basic) (2021 - 2026)
Immix Biopharma (IMMX) posted EPS (Basic) of -$0.18 for Q1 2026, down 148.86% sequentially from -$0.07 in Q4 2025, and down 19.11% YoY from -$0.23 in Q1 2025.
Powered by 
Analysis
Immix Biopharma (IMMX) EPS (Basic) (2021 - 2026) Analysis & Trends
Immix Biopharma has reported EPS (Basic) for 6 years, with the latest figure at -$0.18 in Q1 2026.
- Quarterly EPS (Basic) fell 19.11% year-over-year to -$0.18 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.48 (down 1702.08% YoY) and the FY2025 annual result came in at -$0.64, down 1046.75% from the prior year.
- EPS (Basic) eased to -$0.18 in Q1 2026 per IMMX's latest filing, from -$0.07 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.54 in Q4 2024 and troughed at -$0.24 in Q3 2024.
- A 5-year average of -$0.12 and a median of -$0.15 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) surged 1243.92% in 2024, then tumbled 113.53% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.15 in 2022, then soared by 68.01% to -$0.05 in 2023, then soared by 1243.92% to $0.54 in 2024, then sank by 113.53% to -$0.07 in 2025, then slumped by 148.86% to -$0.18 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.18, -$0.07, and -$0.24 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Immix Biopharma | 889.29 Mn | 889.29 Mn | - | -0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -0.23 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.24 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -4.80 |
| Sep 30, 2021 | -0.12 |